KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,924 | -1.2% | 189 | 0.0% | 0.00% | – |
| Q2 2023 | $22,189 | +54.8% | 189 | +5.6% | 0.00% | – |
| Q1 2023 | $14,331 | -5.8% | 179 | -6.8% | 0.00% | – |
| Q4 2022 | $15,210 | -10.5% | 192 | -20.0% | 0.00% | – |
| Q3 2022 | $17,000 | -37.0% | 240 | -40.9% | 0.00% | – |
| Q2 2022 | $27,000 | -40.0% | 406 | -39.5% | 0.00% | – |
| Q1 2022 | $45,000 | -22.4% | 671 | -19.6% | 0.00% | – |
| Q4 2021 | $58,000 | +866.7% | 835 | +659.1% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 110 | +17.0% | 0.00% | – |
| Q2 2021 | $6,000 | -62.5% | 94 | -54.1% | 0.00% | – |
| Q1 2021 | $16,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | +12.5% | 205 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |